Data from Médecine Intensive Réanimation - Curated by EPG Health - Date available 03 November 2017
Availability
Free full text
Original date published
3 November 2017
Original format
Print publication
Fulminant myocarditis is a rare inflammatory affecting relatively young adult. We report a case of 29-year-old pregnant woman with an acute intraoperative onset of a severe heart failure. A rapid and accurate diagnostic approach suggested an acute fulminant myocarditis. Initial hemodynamic support without immunosuppressive and viral therapy resulted in a partial recovery within a two week. Patients presenting with acute fulminant myocarditis with unknown etiology can have a complete recovery with an appropriate and rapid timing of an aggressive hemodynamic support including levosimendan and extracorporeal membrane oxygenation.
(Article in French)
Data sources
Read abstract on library site Access full article
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Acute and Advanced Heart Failure
What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...
+ 3 more
Fabry Disease
Explore the pathophysiology and treatment options for Fabry disease, a deficiency of the lysosomal enzyme alpha-galactosidase A
Transplantation
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Oral Anticoagulation Reversal
Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.
Cushing's Syndrome
Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?
+ 2 more
Chronic Lymphocytic Leukaemia (CLL)
Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more
+ 1 more
Related Content
ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery.
Coronary artery disease (CAD) is one of the leading causes of death and disability in Europe and worldwide.
Added 3 months ago
Levosimendan in patients with cardiogenic shock complicating myocardial infarction: A meta-analysis.
Cardiac shock is the leading cause of death in patients with acute myocardial infarction.
Added 3 months ago
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
Background: We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention.
Added 6 months ago
Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation.
Background: Adherence to oral anticoagulant (OAC) agents is important for patients with nonvalvular atrial fibrillation (NVAF) to prevent potentially severe adverse events.
Added 6 months ago
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.
Background: Rivaroxaban is an oral anticoagulant approved in the US for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF).
Added 6 months ago
FDA approves AngelMed Guardian System to detect acute coronary syndrome events.- Angel Medical Systems.
Angel Medical Systems, Inc. has received FDA premarket approval (PMA) for the ‘AngelMed Guardian System’. The AngelMed Guardian System is...
Added 2 days ago
Sub analysis of PEGASUS-TIMI 54 study shows risk reduction with use of Brilinta in heart attack survivors.-AstraZeneca
AstraZeneca announced results from a new sub-analysis of the Phase III PEGASUS-TIMI 54 trial, demonstrating a risk reduction of 19%...
Added 2 months ago
Are standard medical tests good enough to diagnose heart attacks?
Study reveals the danger of poor diagnosis, which may lead to two-thirds of heart attacks being missed.
Added 2 months ago
Magnetic nanoparticles could help rejuvenate damaged hearts
An interdisciplinary team has been investigating a new approach using replacement cells that contain magnetic nanoparticles, allowing them to be held in place.
Added 4 months ago
Xarelto found to improve patient outcomes with PAD and CAD
COMPASS trial showed that Xarelto (rivaroxaban) from Bayer and Janssen significantly cut the amputation rate for patients with peripheral artery disease (PAD) and a 23% reduction in deaths in patients with coronary artery disease (CAD).
Added 5 months ago
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
The purpose of this study is to determine whether rivaroxaban in addition to standard care reduces the risk of the composite of cardiovascular death, myocardial infarction, or stroke in patients...
Added 6 months ago
Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)
The primary purpose of this study is to evaluate whether treatment with rivaroxaban and aspirin or rivaroxaban alone is better than aspirin alone in prevention of heart attacks, stroke or cardiovascular death...
Added 6 years ago
Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG)
The purpose of the study is to investigate the benefits of switching away from a kind of drug called a...
Added 5 years ago
Tenofovir Abacavir Platelet Activation Study (TAPAS)
Some but not all observational studies have found that current exposure to abacavir is associated with increased risk of cardiovascular...
Added 5 years ago
T1 Mapping in HIV Patients With High and Low CD4+ Cell Counts
HIV-infection is associated with an increased risk for cardiovascular disease. Especially patients with low CD4+ counts have a higher incidence...
Added 5 years ago
Acute coronary syndrome
This guideline provides recommendations for the management of patients with ACS within the first 12 hours and up to hospital discharge.
Added 6 months ago
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
The present document deals with the management of patients with suspected NSTE-ACS, replacing the document first published in 2000 and...
Added 2 years ago
2014 ESC/EACTS Guidelines on myocardial revascularization
In 2014, coronary artery bypass grafting (CABG) celebrates the 50th anniversary of the first procedures performed in 1964. Thirteen years later, the first percutaneous coronary intervention (PCI) was performed.
Added 3 years ago
MI – secondary prevention: Secondary prevention in primary and secondary care for patients following a myocardial infarction
Myocardial infarction (MI) is one of the most dramatic presentations of coronary artery disease. It is usually caused by blockage...
Added 4 years ago
Comments
You will need to login, to leave a comment.
epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.